Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for BetterLife Pharma Inc. (BETRF : OTC)

• Company Description    BetterLife Pharma Inc. is a science-based medical wellness company. It developed pharmaceutical grade products including CBD, phytocannabinoid and micronutrient derived formulations utilizing proprietary drug delivery technologies. BetterLife Pharma Inc., formerly known as Pivot Pharmaceuticals Inc., is based in Vancouver, Canada. Number of Employees: 4

• Price / Volume Information    Yesterday's Closing Price: $0.07 Daily Weekly Monthly 20 Day Moving Average: 20,116 shares Shares Outstanding: 129.46 (millions) Market Capitalization: $9.39 (millions) Beta: 1.45 52 Week High: $0.14 52 Week Low: $0.05 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 9.85% 5.73% 12 Week 13.28% -4.72% Year To Date 0.69% -5.70%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1275 West 6th Avenue Suite300 - VANCOUVER,A1 V6H 1A6 CAN ph: 438-884-8841 fax: - ir@blifepharma.com http://www.abetterlifepharma.com

• General Corporate Information    Officers Ahmad Doroudian - Chief Executive Officer Hooshmand Sheshbaradaran - Chief Operating Officer Moira Ong - Chief Financial Officer Robert Metcalfe - Director Anthony Pullen - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 08772P202 SIC: 2834 Fiscal Year Fiscal Year End: January Last Reported Quarter: 04/01/25 Next Expected EPS Date: 09/24/25 Share - Related Items Shares Outstanding: 129.46 Most Recent Split Date: 6.00 (0.10:1) Beta: 1.45 Market Capitalization: $9.39 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 09/24/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 100.00% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 04/30/25 - - 01/31/25 - - 10/31/24 - - ROA 04/30/25 - -609.07 01/31/25 - -1,124.01 10/31/24 - -999.57 Current Ratio 04/30/25 - 0.04 01/31/25 - 0.03 10/31/24 - 0.05 Quick Ratio 04/30/25 - 0.04 01/31/25 - 0.03 10/31/24 - 0.05 Operating Margin 04/30/25 - - 01/31/25 - - 10/31/24 - - Net Margin 04/30/25 - - 01/31/25 - - 10/31/24 - - Pre-Tax Margin 04/30/25 - - 01/31/25 - - 10/31/24 - - Book Value 04/30/25 - -0.03 01/31/25 - -0.04 10/31/24 - -0.04 Inventory Turnover 04/30/25 - - 01/31/25 - - 10/31/24 - - Debt-to-Equity 04/30/25 - - 01/31/25 - - 10/31/24 - - Debt-to-Capital 04/30/25 - - 01/31/25 - - 10/31/24 - -

Powered by Zacks Investment Research ©